Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nguyen-Thanh Hoa has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Yao-Chi Chung

    Graduate Institute of Animal Vaccine Technology, College of Veterinary Medicine, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan

    3 shared publications
  • Asad Murtaza

    Faculty of Biosciences, Fisheries and Economics, Norwegian College of Fishery Science, UiT—The Arctic University of Norway, P.O. Box 6050 Tromsø, Norway

    2 shared publications
  • Haroon Afzal

    International Program in Animal Vaccine Technology, International College, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan

    2 shared publications
  • Chia-Hung Yen

    Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807378, Taiwan

    1 shared publication
  • Chun-Yen Chu

    International Program in Animal Vaccine Technology, National Pingtung University Science and Technology, Pingtung 91201, Taiwan; Graduate Institute of Animal Vaccine Technology, College of Veterinary Medicine, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan

    1 shared publication
  • Do Dieu-Huong

    International Program in Animal Vaccine Technology, International College, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan

    1 shared publication

Latest Publications

  • Open Access

    Utilizing NF-κB Signaling in Porcine Epithelial Cells to Identify a Plant-Based Additive for the Development of a Porcine Epidemic Diarrhea Virus Vaccine

    by Nguyen-Thanh Hoa, Haroon Afzal, Thu-Dung Doan, Asad Murtaza, Chia-Hung Yen, Yao-Chi Chung

    The nuclear factor-kappa B (NF-κB) signaling pathway plays a crucial role in regulating immune responses in epithelial cells. In this study, we established a porcine epithelial NF-κB reporter cell line (PK15-KBR) as an in vitro platform to screen plant-based extracts for their potential use as vaccine adjuvants against porcine epidemic diarrhea virus (PEDV). The NF-κB inducers were further tested for toxicity assessments, either using CCK-8 assays or intramuscular injection in mice, finally followed by vaccination studies to evaluate their adjuvancy. Initial experiments confirmed that TNF-α effectively activated NF-κB signaling in PK15-KBR cells in a dose-dependent manner, validating the platform’s reliability at Z’ value of 0.68. Of the 224 testers, 3 candidates, including chamomile, mulberry and Boerhaavia diffusa, showed induction activity; however, only chamomile induced a dose-dependent response in PK15-KBR cells. As a proof of concept, chamomile, used as an adjuvant in oral vaccination, demonstrated significantly higher IgG levels at an early stage (day 14, p < 0.05) and enhanced IgA titers. These findings highlight the use of the PK15-KBR cell line in identifying mucosal adjuvants and position chamomile extract as a promising candidate for enhancing vaccine-induced immunity.

  • Enhanced immune response with baculovirus-expressed BoHV-1 glycoprotein D in vaccine development

    by Nguyen-Thanh Hoa, Haroon Afzal, Uudamsaikhan Gundegmaa, Odbileg Raadan, Li-Ting Cheng, Chun-Yen Chu, Thu-Dung Doan, Yao-Chi Chung


  • Open Access

    Advancing PEDV Vaccination: Comparison between Inactivated and Flagellin N-Terminus-Adjuvanted Subunit Vaccines

    by Asad Murtaza, Nguyen-Thanh Hoa, Do Dieu-Huong, Haroon Afzal, Muhammad Hamza Tariq, Li-Ting Cheng, Yao-Chi Chung

    Vaccinations can serve as an important preventive measure against the porcine epidemic diarrhea (PED) virus that currently threatens the swine industry. This study focuses on the development of a fusion protein vaccine, FliC99-mCOE, which combines the N-terminus of flagellin (FliC99) with a modified core neutralizing epitope (mCOE) of PEDV. In silico immunoinformatic analysis confirmed the construct’s non-toxic, non-allergenic, and highly antigenic nature. Molecular docking and molecular dynamics (MD) simulations demonstrated FliC99-mCOE’s strong binding to the TLR-5 immunological receptor. Repeated exposure simulations and immunological simulations suggested enhanced cell-mediated immunity. Both FliC99-mCOE and an inactivated PEDV vaccine were produced and tested in mice. The results from cell proliferation, ELISA, and neutralization assays indicated that FliC99-mCOE effectively stimulated cellular immunity and neutralized PEDV. We conclude that the FliC99-mCOE fusion protein may serve as a promising vaccine candidate against PEDV.